{
    "clinical_study": {
        "@rank": "41809", 
        "arm_group": [
            {
                "arm_group_label": "Placebo BID", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "5mg BID CP-690,550", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "10mg BID CP-690,550", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this study is to compare the efficacy of CP-690,550 (5 mg BID and\n      10 mg BID) versus placebo for the reduction in severity of plaque psoriasis after 16 weeks\n      of treatment in Asian subjects with moderate to severe chronic plaque psoriasis who are\n      candidates for systemic therapy or phototherapy."
        }, 
        "brief_title": "A Study Evaluating The Efficacy And Safety oO CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Psoriasis", 
        "condition_browse": {
            "mesh_term": "Psoriasis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have had a diagnosis of plaque-type psoriasis (psoriasis vulgaris) for at least 12\n             months prior to the first screening procedure.\n\n          -  Have a PASI score of 12 or greater AND a PGA score of 3 (\"moderate\") or 4 (\"severe\")\n             at Baseline (Day 1).\n\n          -  Considered by dermatologist investigator to be a candidate for systemic therapy or\n             phototherapy of psoriasis (either na\u00efve or history of previous treatment).\n\n        Exclusion Criteria:\n\n          -  Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular\n             psoriasis, with the exception of nail psoriasis which is allowed.\n\n          -  Have current drug induced psoriasis, eg, a new onset of psoriasis or an exacerbation\n             of psoriasis from beta blockers, calcium channel blockers, antimalarial drugs or\n             lithium.\n\n          -  Subjects who cannot discontinue systemic therapies and/or topical therapies for the\n             treatment of psoriasis and cannot discontinue phototherapy (UVB or PUVA) for the\n             study are excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "264", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01815424", 
            "org_study_id": "A3921174"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo BID", 
                "description": "placebo BID for 16 weeks and then re-randomized into active groups", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "5mg BID CP-690,550", 
                "description": "CP-690,550 5mg BID for 52 weeks", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "10mg BID CP-690,550", 
                "description": "CP-690,550 10mg BID for 52 weeks", 
                "intervention_name": "CP-690,550", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Tofacitinib", 
            "CP-690", 
            "550", 
            "Xeljanz", 
            "Jak-Inhibitor", 
            "Oral Treatment", 
            "Psoriasis vulgaris", 
            "Pruritus", 
            "Itch", 
            "DLQI", 
            "moderate", 
            "severe", 
            "chronic", 
            "plaque psoriasis"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3921174&StudyName=A%20Study%20Evaluating%20The%20Efficacy%20And%20Safety%20oO%20CP-690%2C550%20In%20Asian%20Subjects%20With%20Moderate%20To%20Severe%20Plaque%20Psoriasis"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Xicheng District", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100050"
                    }, 
                    "name": "Dept. Of dermatology &STD, Beijing Friendship Hospital, Capital Medical University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510120"
                    }, 
                    "name": "Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430022"
                    }, 
                    "name": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430030"
                    }, 
                    "name": "Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "210042"
                    }, 
                    "name": "Hospital of Skin Diseases, Chinese Academy of Medical Sciences"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dalian", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "116027"
                    }, 
                    "name": "Department of Dermatology, The Second Affiliated Hospital of Dalian Medical University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200040"
                    }, 
                    "name": "Huashan Hospital, Fudan University/Dermatology Department"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200433"
                    }, 
                    "name": "Shanghai Changhai Hospital, Dermatology Department"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xi'an", 
                        "country": "China", 
                        "state": "Shanxi", 
                        "zip": "710032"
                    }, 
                    "name": "Dermatology Department, The First Affiliated Hospital, The Fourth Military Medical University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "West China Hospital of Sichuan University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610031"
                    }, 
                    "name": "Sichuan Provincial People's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310009"
                    }, 
                    "name": "The Second Affiliated Hospital of College of Medicine, Zhejiang University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310003"
                    }, 
                    "name": "The First Affiliated Hospital of College of Medicine, Zhejiang University/Dermatology and STD Dept"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100034"
                    }, 
                    "name": "Peking University First Hospital / The Department of Dermatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100044"
                    }, 
                    "name": "Peking University People's Hospital/Dermatology Department"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100730"
                    }, 
                    "name": "Beijing Hospital of the Ministry of Health/Department of Dermatology"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "zip": "300052"
                    }, 
                    "name": "Tianjin Medical University General Hospital, Dermatological Department"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Seoul National University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "120-452"
                    }, 
                    "name": "Department of Dermatology,Severance Hospital, Yonsei University Health System"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul,", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Department of Dermatology,SAMSUNG MEDICAL CENTER"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tainan", 
                        "country": "Taiwan", 
                        "zip": "704"
                    }, 
                    "name": "National Cheng-Kung University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "zip": "100"
                    }, 
                    "name": "National Taiwan University Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taoyuan", 
                        "country": "Taiwan", 
                        "zip": "333"
                    }, 
                    "name": "Chang Gung Medical Foundation-Linkou Branch"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "China", 
                "Korea, Republic of", 
                "Taiwan"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Of The Efficacy And Safety Of 2 Oral Doses Of CP- 690,550 In Asian Subjects With Moderate To Severe Chronic Plaque Psoriasis", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "PGA of Psoriasis scale ranges from 0 (no psoriasis) to 5 (severe disease).  'Clear' and \"Almost clear' includes all participants who were scored as a 0 or 1", 
                "measure": "Physician Global Assessment (PGA) of Psoriasis Score", 
                "safety_issue": "No", 
                "time_frame": "Week 16"
            }, 
            {
                "measure": "Psoriasis Area and Severity Index 75 (PASI75) response, the proportion of participants achieving at least 75% reduction in PASI relative to baseline at Week 16", 
                "safety_issue": "No", 
                "time_frame": "Week 16"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01815424"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).", 
                "measure": "Dermatology Life Quality Index (DLQI) Total Score", 
                "safety_issue": "No", 
                "time_frame": "Week 16"
            }, 
            {
                "description": "PGA of Psoriasis scale ranges from 0 (no psoriasis) to 5 (severe disease).  'Clear' and \"Almost clear' includes all participants who were scored as a 0 or 1.", 
                "measure": "Physician Global Assessment (PGA) of Psoriasis Score", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "description": "DLQI is the dermatology-specific quality of life measure used for psoriatic population. The 10-item questionnaire has a score range of 0 to 30 with higher scores indicating poor quality of life. An estimate of the minimal clinically important difference of the DLQI total score is a 5 point improvement. Total score range: 0 (best) to 30 (worst).", 
                "measure": "Dermatology Life Quality Index (DLQI) Total Score", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}